ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

Agriculture Dept. Asks clearinghouse To Consider Broader Risk Assessment Data

July 14, 1978

Includes June issue of Business & Regulatory Report.

June 28, 2002

In Brief: NCAB To Protest Tobacco Ads In ‘Family Circle’; ACS Petitions For Taxol Source Designation

October 19, 1990

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006